Literature DB >> 1851695

Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects.

B M Fisher1, J D Quin, A Rumley, S E Lennie, M Small, A C MacCuish, G D Lowe.   

Abstract

1. The effects of acute hypoglycaemia on haemostasis, fibrinolysis, blood viscosity and erythrocyte aggregation were examined after acute insulin-induced hypoglycaemia in six normal male subjects and in six male patients with poorly controlled insulin-dependent diabetes. In the control subjects hypoglycaemia caused a significant increase in the concentration of von Willebrand factor, with no change in the concentrations of fibrinogen and cross-linked fibrin degradation products. Fibrinolysis was enhanced, as indicated by significant increases in tissue plasminogen activator concentration and the fibrin plate lysis area, with a fall in plasminogen-activator inhibitor activity, suggesting complex formation. Whole-blood and plasma viscosity increased significantly after hypoglycaemia, but there was no significant change in erythrocyte aggregation tendency. 2. In diabetic patients the increase in the concentration of von Willebrand factor was significantly greater than in the control group (analysis of variance, P less than 0.02). The basal concentration of tissue plasminogen activator was reduced at 3.7 +/- 0.7 mg/l (mean +/- SEM) in the diabetic group compared with 8.5 +/- 1.3 mg/l in the control group (Student's t-test, P less than 0.01), but thereafter the increase in response to hypoglycaemia was similar. The changes in the other variables were not significantly different from the changes in the control group. 3. During acute hypoglycaemia in poorly controlled diabetic patients there is promotion of haemostasis with a greater increase in the concentration of von Willebrand factor, which, in association with the increase in viscosity, might reduce perfusion in diabetic microangiopathy, leading to aggravation of the microvascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851695     DOI: 10.1042/cs0800525

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  The change of macular thickness measured by optical coherence tomography in relation to glycemic control in diabetic patients.

Authors:  Sang Woong Moon; Hee-Young Kim; Seong-Woo Kim; Jaeryung Oh; Kuhl Huh; In Kyung Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-26       Impact factor: 3.117

Review 2.  Exposure to hypoglycemia and risk of stroke.

Authors:  Logan Smith; Diya Chakraborty; Pallab Bhattacharya; Deepaneeta Sarmah; Sebastian Koch; Kunjan R Dave
Journal:  Ann N Y Acad Sci       Date:  2018-06-19       Impact factor: 5.691

3.  The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.

Authors:  Chutatip Limkunakul; Ian H de Boer; Bryan R Kestenbaum; Jonathan Himmelfarb; T Alp Ikizler; Cassianne Robinson-Cohen
Journal:  J Diabetes Complications       Date:  2019-01-07       Impact factor: 2.852

4.  Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes.

Authors:  Rohana J Wright; David E Newby; David Stirling; Christopher A Ludlam; Ian A Macdonald; Brian M Frier
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

5.  Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.

Authors:  Grzegorz Gajos; Malgorzata Konieczynska; Jaroslaw Zalewski; Anetta Undas
Journal:  Cardiovasc Diabetol       Date:  2015-05-01       Impact factor: 9.951

6.  Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans.

Authors:  Ahmed Iqbal; Lynne R Prince; Peter Novodvorsky; Alan Bernjak; Mark R Thomas; Lewis Birch; Danielle Lambert; Linda J Kay; Fiona J Wright; Ian A Macdonald; Richard M Jacques; Robert F Storey; Rory J McCrimmon; Sheila Francis; Simon R Heller; Ian Sabroe
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

7.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

8.  Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-05-06       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.